Christopher K. Rayner

13.1k total citations · 1 hit paper
288 papers, 9.8k citations indexed

About

Christopher K. Rayner is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Surgery. According to data from OpenAlex, Christopher K. Rayner has authored 288 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 158 papers in Endocrinology, Diabetes and Metabolism, 129 papers in Physiology and 83 papers in Surgery. Recurrent topics in Christopher K. Rayner's work include Diabetes Treatment and Management (127 papers), Diet and metabolism studies (121 papers) and Diabetes Management and Research (64 papers). Christopher K. Rayner is often cited by papers focused on Diabetes Treatment and Management (127 papers), Diet and metabolism studies (121 papers) and Diabetes Management and Research (64 papers). Christopher K. Rayner collaborates with scholars based in Australia, China and United Kingdom. Christopher K. Rayner's co-authors include Michael Horowitz, Karen L. Jones, Tongzhi Wu, Judith M. Wishart, Richard L. Young, Chinmay S. Marathe, Christine Feinle‐Bisset, Jing Ma, Melvin Samsom and Adam M. Deane and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Christopher K. Rayner

276 papers receiving 9.6k citations

Hit Papers

Gastrointestinal effects ... 2024 2026 2024 10 20 30 40

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Christopher K. Rayner 4.5k 3.8k 2.9k 1.8k 1.8k 288 9.8k
Bolette Hartmann 6.1k 1.4× 3.3k 0.9× 4.6k 1.6× 2.6k 1.4× 944 0.5× 359 12.2k
Christine Feinle‐Bisset 1.8k 0.4× 3.6k 1.0× 1.7k 0.6× 2.0k 1.1× 1.6k 0.9× 177 8.1k
Judith M. Wishart 2.0k 0.4× 3.2k 0.8× 1.4k 0.5× 1.6k 0.9× 1.2k 0.6× 101 6.5k
Duane D. Burton 1.1k 0.2× 3.5k 0.9× 5.1k 1.7× 1.3k 0.7× 7.6k 4.2× 222 12.1k
Claude Knauf 1.8k 0.4× 5.1k 1.3× 2.1k 0.7× 1.2k 0.7× 685 0.4× 99 11.6k
Lars Fändriks 915 0.2× 2.0k 0.5× 2.2k 0.7× 361 0.2× 743 0.4× 179 5.7k
Ken Fujioka 3.4k 0.8× 3.6k 0.9× 1.5k 0.5× 1.0k 0.6× 133 0.1× 109 8.5k
Martin Storr 846 0.2× 1.4k 0.4× 1.7k 0.6× 462 0.3× 1.9k 1.0× 226 7.4k
Peter C. Konturek 524 0.1× 1.0k 0.3× 2.8k 1.0× 957 0.5× 802 0.4× 186 6.4k
Jussi Pihlajamäki 2.4k 0.5× 3.6k 0.9× 2.5k 0.8× 688 0.4× 241 0.1× 231 11.3k

Countries citing papers authored by Christopher K. Rayner

Since Specialization
Citations

This map shows the geographic impact of Christopher K. Rayner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher K. Rayner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher K. Rayner more than expected).

Fields of papers citing papers by Christopher K. Rayner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher K. Rayner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher K. Rayner. The network helps show where Christopher K. Rayner may publish in the future.

Co-authorship network of co-authors of Christopher K. Rayner

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher K. Rayner. A scholar is included among the top collaborators of Christopher K. Rayner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher K. Rayner. Christopher K. Rayner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Xiaoying, Tongzhi Wu, Shanhu Qiu, et al.. (2025). Variations in blood pressure after a 75 g oral glucose load and their implications for detecting hypertension and postprandial hypotension in Chinese adults: a cross-sectional study. European Journal of Preventive Cardiology. 32(14). 1382–1391.
2.
Huang, Weikun, et al.. (2024). Sex differences in the plasma glucagon responses to a high carbohydrate meal and a glucose drink in type 2 diabetes. Diabetes Research and Clinical Practice. 214. 111769–111769. 2 indexed citations
3.
Portmann, Luc, et al.. (2024). P825 Comprehensive dietitian-delivered dietary advice effectively achieves dietary change in adults with Ulcerative Colitis, whereas generalised written dietary advice does not. Journal of Crohn s and Colitis. 18(Supplement_1). i1527–i1527. 1 indexed citations
4.
Sun, Yixuan, Chunjie Xiang, Weikun Huang, et al.. (2024). Gastric emptying in newly diagnosed, treatment‐naïve Han Chinese with type 2 diabetes and the impact of 4‐week insulin pump therapy. Diabetes Obesity and Metabolism. 26(8). 3078–3087. 1 indexed citations
6.
Xiang, Chunjie, Yixuan Sun, Cong Xie, et al.. (2024). Gastric emptying is slower in women than men with type 2 diabetes and impacts on postprandial glycaemia. Diabetes Obesity and Metabolism. 26(8). 3119–3127. 3 indexed citations
7.
Xiang, Chunjie, Yixuan Sun, Cong Xie, et al.. (2024). Gastric emptying of a glucose drink is predictive of the glycaemic response to oral glucose and mixed meals, but unrelated to antecedent glycaemic control, in type 2 diabetes. Nutrition and Diabetes. 14(1). 13–13. 3 indexed citations
8.
Wang, Xuyi, Chang Chen, Cong Xie, et al.. (2022). Serum bile acid response to oral glucose is attenuated in patients with early type 2 diabetes and correlates with 2‐hour plasma glucose in individuals without diabetes. Diabetes Obesity and Metabolism. 24(6). 1132–1142. 13 indexed citations
9.
Xie, Cong, et al.. (2019). Mechanism of glucose‐lowering by metformin in type 2 diabetes: Role of bile acids. Diabetes Obesity and Metabolism. 22(2). 141–148. 61 indexed citations
10.
Veedfald, Simon, Tongzhi Wu, Bolette Hartmann, et al.. (2018). Hyperosmolar Duodenal Saline Infusion Lowers Circulating Ghrelin and Stimulates Intestinal Hormone Release in Young Men. The Journal of Clinical Endocrinology & Metabolism. 103(12). 4409–4418. 20 indexed citations
11.
Sullivan, Thomas, Andrew Tai, Judith Morton, et al.. (2018). Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: A randomized crossover trial. Diabetes Obesity and Metabolism. 21(3). 700–704. 33 indexed citations
12.
Young, Richard L., Nicole J. Isaacs, Gudrun Schober, et al.. (2017). Impact of artificial sweeteners on glycaemic control in healthy humans. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 4 indexed citations
13.
Rayner, Christopher K., Tongzhi Wu, Michael Horowitz, & Karen L. Jones. (2017). Blockade of glucagon-like peptide-1 receptors by exendin(9-39) attenuates the increase in heart rate during small intestinal glucose infusion in type 2 diabetes. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 1 indexed citations
14.
Wu, Tongzhi, Michael Horowitz, Karrie L. Jones, & Christopher K. Rayner. (2017). Endogenous glucagon-like peptide-1 mediates the lowering of glycaemia during small intestinal glucose infusion by bile acids in type 2 diabetes. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 2 indexed citations
15.
Feng, Rilu, Cheng Qian, Qianjing Liu, et al.. (2017). Expression of sweet taste receptor and gut hormone secretion in modelled type 2 diabetes. General and Comparative Endocrinology. 252. 142–149. 14 indexed citations
16.
Wu, T. John, Anna C. Phillips, Helen Checklin, et al.. (2016). A whey/guar "preload" improves postprandial glycaemia and HbA(1c) in type 2 diabetes: a 12-week, single-blind, randomised and placebo controlled trial. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 1 indexed citations
17.
Standfield, Scott, Shanming Hu, Karen L. Jones, et al.. (2016). Comparative effects of proximal and distal small intestinal glucose on glycaemia, incretin hormone secretion and incretin effect in healthy males. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 1 indexed citations
18.
Little, Tanya J., Nicole J. Isaacs, Richard L. Young, et al.. (2014). Characterization of duodenal expression and localization of fatty acid-sensing receptors in humans: relationships with body mass index. American Journal of Physiology-Gastrointestinal and Liver Physiology. 307(10). G958–G967. 43 indexed citations
19.
Chang, Jessica, Christopher K. Rayner, Karen L. Jones, & Michael Horowitz. (2013). Prognosis of diabetic gastroparesis—a 25‐year evaluation. Diabetic Medicine. 30(5). e185–8. 28 indexed citations
20.
Stevens, Julie E., Michael Horowitz, Carolyn F. Deacon, et al.. (2012). The effects of sitagliptin on gastric emptying in healthy humans – a randomised, controlled study. Alimentary Pharmacology & Therapeutics. 36(4). 379–390. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026